Aug 222012
We’re happy to announce that we’re attending, presenting and co-sponsoring the first annual Sickle Cell Disease Therapeutics Conference the third week of September, Wednesday 9/19. This is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease. Brinson Patrick Managing Director and life sciences analyst Michael Higgins will be co-presenting The Patient Experience Q&A with sickle cell disease patient Andre Louissaint. Learn more here, and see you there.